ストックスクリーナーアプリを入手
1.30
3.70%
-0.05
アフターアワーズ：
1.28
-0.02
-1.54%
前日終値:
$1.35
開ける：
$1.37
24時間の取引高:
121.43K
Relative Volume:
1.06
時価総額：
$9.80M
収益：
-
当期純損益:
$-25.56M
株価収益率:
-0.25
EPS:
-5.2
ネットキャッシュフロー:
$-19.35M
1週間 パフォーマンス:
+12.07%
1か月 パフォーマンス:
-18.24%
6か月 パフォーマンス:
-84.65%
1年 パフォーマンス:
-44.92%
1日の値動き範囲:
$1.27
$1.37
1週間の範囲:
$1.13
$1.425
52週間の値動き範囲:
$0.62
$9.56
Biovie Inc Stock (BIVI) Company Profile
BIVI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
1.30 | 10.18M | 0 | -25.56M | -19.35M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-07-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-01-15 | 開始されました | B. Riley Securities | Buy |
Biovie Inc (BIVI) 最新ニュース
Will BioVie Inc. stock see insider buyingMarket Activity Report & Expert Approved Momentum Ideas - ulpravda.ru
BioVie completes enrollment for Parkinson’s drug trial By Investing.com - Investing.com Australia
BioVie completes enrollment for Parkinson’s drug trial - Investing.com
BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson’s Disease - GlobeNewswire
Is BioVie Inc. stock dividend yield sustainableSmall Cap Stock Opportunities & Affordable Market Insights - ulpravda.ru
Aug Shorts: Why BioVie Inc stock is rated strong buyWeekly Stock Analysis & High Accuracy Trade Signal Alerts - moha.gov.vn
HALPER SADEH LLC ENCOURAGES BIOVIE INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - The Malaysian Reserve
BioVie (NASDAQ:BIVI) Trading Down 5.8% – What’s Next? - Defense World
BioVie Inc Stock Analysis and ForecastEconomic Impact on Stocks & Free Real-Time Stock Market Data - earlytimes.in
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Daily Commercial
Will BioVie Inc. stock outperform Dow Jones indexJuly 2025 Snapshot & Fast Gain Stock Trading Tips - ulpravda.ru
BioVie advances lead drug candidatesICYMI - Proactive financial news
Breakout Zone: Will BioVie Inc. stock outperform Dow Jones indexJobs Report & Reliable Price Breakout Alerts - Улправда
Why retail investors pile into BioVie Inc. stockJuly 2025 Technicals & Reliable Entry Point Alerts - Улправда
What Wall Street predicts for BioVie Inc. stock priceMarket Performance Summary & Stepwise Swing Trade Plans - Улправда
Aug Movers: How BioVie Inc. stock compares to industry benchmarksJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - Улправда
How BioVie Inc. stock compares to industry benchmarks2025 EndofYear Setup & Precise Buy Zone Identification - ulpravda.ru
Why BioVie Inc. stock is rated strong buyJuly 2025 Retail & Reliable Entry Point Trade Alerts - DonanımHaber
Fund Flows: What momentum indicators show for BioVie Inc. stockJuly 2025 Outlook & Daily Chart Pattern Signal Reports - Улправда
What momentum indicators show for BioVie Inc. stockQuarterly Performance Summary & Technical Confirmation Trade Alerts - Улправда
BioVie advances Parkinson’s, long COVID, and liver disease programs ahead of 2026 - Proactive financial news
What makes BioVie (BIVI) a new buy stock - MSN
What Makes BioVie (BIVI) a New Buy Stock - sharewise.com
BioVie Inc. (BIVI) Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver DiseaseSlideshow (NASDAQ:BIVI) 2025-12-09 - Seeking Alpha
New to The Street Broadcasts Tonight on Bloomberg at 6:30 PM EST Featuring Roadzen, BioVie, and TY J Young Wealth - The Florida Times-Union
Breakout Watch: How BioVie Inc. stock compares to industry benchmarksPortfolio Performance Summary & Safe Capital Growth Trade Ideas - BỘ NỘI VỤ
Can BioVie Inc. stock sustain institutional interestJuly 2025 Review & Low Drawdown Trading Strategies - Newser
BioVie Inc. (BIVI) -5.7% in After-hours: Stock Declines Amid Routine Trading Conditions - Stocks Telegraph
BioVie (NASDAQ:BIVI) Shares Up 0.3% – Here’s What Happened - Defense World
BIVI SEC FilingsBiovie Inc 10-K, 10-Q, 8-K Forms - Stock Titan
[S-8] BIOVIE INC. Employee Benefit Plan Registration | BIVI SEC FilingForm S-8 - Stock Titan
BIVIW Insider Trading - Quiver Quantitative
BIVIW | BioVie Inc. Warrant Stock Data, Price & News - Quiver Quantitative
BioVie Inc. (BIVI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What drives BioVie Inc stock pricePrice Support Zones & Free Record-Breaking Gains - earlytimes.in
What catalysts could drive BioVie Inc. stock higherMarket Performance Summary & Consistent Growth Stock Picks - newser.com
Biotech Stocks Swing After Hours: Delcath Rises On Buyback, BioVie And Cassava Rebound - Nasdaq
Will BioVie Inc. stock outperform Nasdaq index2025 Market Overview & Daily Oversold Bounce Ideas - newser.com
How BioVie Inc. stock performs in stagflation2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - newser.com
Is BioVie Inc. stock safe for conservative investorsJuly 2025 Decliners & Expert Verified Stock Movement Alerts - newser.com
How currency fluctuations impact BioVie Inc. stockOil Prices & Weekly Watchlist of Top Performers - newser.com
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on December 9 - The Manila Times
Biovie Inc (BIVI) 財務データ
収益
当期純利益
現金流量
EPS
0.80%
4.56%
大文字化:
|
ボリューム (24 時間):